|
WO2021003469A2
|
|
Recombinant human sialidases, sialidase fusion proteins, and methods of using the same
|
|
WO2021003464A1
|
|
Sialidase-pd-l1-antibody fusion proteins and methods of use thereof
|
|
WO2021003463A1
|
|
Sialidase-cd20-antibody fusion proteins and methods of use thereof
|
|
WO2021003465A1
|
|
Sialidase-her2-antibody fusion proteins and methods of use thereof
|
|
WO2021003468A2
|
|
Recombinant sialidases and methods of using the same
|
|
WO2020142727A1
|
|
Methods and compositions for treating cancer with immune cells
|
|
EP3802582A1
|
|
Multimeric proteins for detecting a carbohydrate and/or treating a siglec-mediated disorder
|
|
AU2019205912A1
|
|
Recombinant human sialidases, sialidase fusion proteins, and methods of using the same
|
|
US2019023786A1
|
|
Use of siglec-7 or siglec-9 antibodies for the treatment of cancer
|
